TMD1 protein for treating bone loss diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9775885
APP PUB NO 20170216407A1
SERIAL NO

15415806

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for treating a bone loss disease, condition, or disorder in a subject in need thereof, comprising administering to said subject a pharmaceutically effective amount of a composition comprising thrombomodulin lectin-like domain (TMD1).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UCB BIOPHARMA SPRL60 ALLÉE DE LA RECHERCHE BRUSSELS B-1070

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cheng, Tsung-Lin Kaohsiung, TW 3 2
Ho, Mei-Ling Kaohsiung, TW 36 93
Shi, Guey-Yueh Tainan, TW 16 139
Wu, Hua-Lin Tainan, TW 21 142
Yeh, Jwu-Lai Kaohsiung, TW 6 16

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 3, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 3, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00